Doug Killion

Mr. Killion is a seasoned industry executive with 28 years of serial medical device development, clinical evaluation and commercialization experience. He most recently served as President of Sealing Solutions Inc., where he led the company from inception in 2008 to its successful acquisition by St. Jude Medical in 2010. Preceding its acquisition, Sealing Solutions had developed an innovative vascular closure device capable of enabling a wide range of minimally invasive procedures. Prior to joining Sealing Solutions, he held a variety of cross-functional senior management positions at Boston Scientific including global marketing, business development, and program management. During his 13‑year tenure, Doug was responsible for leading four major new business initiatives within the company. Before joining Boston Scientific, he held various medical device engineering and project management positions at SciMed Life Systems.

Mr. Killion earned his MBA in Strategy and Marketing from the University of Minnesota Carlson School of Management, and holds a BS in Mechanical/Biomedical Engineering from the University of Minnesota.

Laurie Lynch, PhD

Dr. Lynch has over 23 years of medical device experience in startup companies in the areas of Product Development, Clinical, Regulatory, Manufacturing and Quality Assurance. As General Manager of Hemosphere (acquired by CryoLife), she was responsible for the successful development and commercialization of the HeRO Vascular Access Device for hemodialysis. In this role she was responsible for all FDA submissions, clinical testing, and created and maintained all quality system functions. Before joining Hemosphere, she was with Advanced Bio-Surfaces where she was lead the operations that were used to sterilize knee and spine device polymers. Prior to Advanced Bio‑Surfaces, Laurie held various positions at Optical Sensors, with primary responsibility for an extracorporeal blood gas sensing device that was commercialized in the U.S.

Dr. Lynch holds a BS in Chemistry from Canisius College, and a Ph.D. in Organic Chemistry from the University of Minnesota.

Keith Modert

Mr. Modert has more than 20 years of product development and manufacturing experience in the medical device industry. Prior to joining Pursuit Vascular, he was responsible for process development, validations, and manufacturing operations that contributed to PMA approval of the LINX device at Torax Medical. Before joining Torax Medical, Keith was an R&D Engineer at Mentor Urology and an R&D Manager and Mentor Urology and Coloplast. As an R&D Engineer, Keith provided technical and project leadership for two PMA approved products and two 510(k) cleared products. As an R&D Manager, he led a team of fifteen employees and managed annual budgets of $3-$4 million to launch six medical devices in three years, while successfully navigating integration into Coloplast.

Mr. Modert has a Bachelor of Chemical Engineering from the University of Minnesota Institute of Technology (now College of Science and Engineering).

Bob Ziebol

Mr. Ziebol has over 25 years of R&D experience. He founded Ziebol & Associates in 1994 and Pursuit Medical in 2008 to help start-up companies develop medical device concepts into commercial products. Bob has successfully demonstrated his abilities in helping build nine companies, taking multiple products from idea to market, and leading diverse teams to successful product outcomes. He has extensive experience in dialysis-related technologies, holds over twenty issued US and foreign patents, and has several patents pending.

Mr. Ziebol holds BS degrees in both Engineering Physics and Electrical Engineering from South Dakota State University.